Riskpilot← Back to searchSign inGet full accessNormLiv AB
ABActiveOrg 5593720575Batterigatan 27 Lgh 1004Computer programming activities · NACE 6210Est. 20220 employees
Revenue 2025
SEK 0
EBITDA margin
—
-6% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -2K
-9% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | -6% |
| Net profit | SEK -2K | -9% |
| Total assets | SEK 15K | -10% |
| Equity | SEK 15K | -10% |
| Employees | 0 | — |
Legal name
NormLiv AB
Org number
5593720575
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
23 mars 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder Styrelsen ska bestå av 5 styrelseledamöter och 0 styrelsesuppleanter.
Company purpose
Utveckling och försäljning av diagnostiska hjälpmedel för läkare, primärvårdare och sjukgymnaster som hjälper till att fatta bättre diagnostiska beslut för hanteringen av muskuloskeletala systemet.
Address
Batterigatan 27 Lgh 1004
Email
poornima2502@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | — | — | — |
| EBITDA | −7 | −2 | −2 |
| Depreciation & amort. | — | — | — |
| EBIT | −7 | −2 | −2 |
| Net financials | — | 0 | 0 |
| Profit before tax | −7 | −1 | −2 |
| Tax | — | — | — |
| Net profit | −7 | −1 | −2 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 18 | 16 | 15 |
| Equity | 18 | 16 | 15 |
| Long-term debt | — | — | — |
| Short-term debt | — | — | — |
| Total debt | — | — | — |
EBITDA margin
-186600.0%
This company
15.8%
Market median
-1181113% vs market
20232025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20232025
Return on equity
-11.0%
This company
18.4%
Market median
-160% vs market
20232025
Net profit margin
-160800.0%
This company
8.1%
Market median
-1985285% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NormLiv AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Poornima Jayamani | Chief Executive Officer | 0 companies |
| Sajid Athikkay | Board of Directors | 0 companies |
| Shanid Muhammed Haneef | Chairman | 0 companies |
| Dominic Sebin Francis | Board of Directors | 0 companies |
| Saima Kaplan | Board of Directors | 0 companies |